arrow
J

Jiandong Huo

guangzhou medical university
H指数:31
被引数:5,718

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters

作者更正: rbd-fc粘膜疫苗在小鼠和仓鼠中提供了针对SARS-CoV-2的防变异保护

2025-07-100
OA
Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases
IMMUNITY
IF26.3
2024-02-015
OA
Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy
2023-06-0725
OAAI
Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses
2023-04-0118
OAAI
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75
2023-01-0140
OAAI
Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation
2022-08-23103
OAAI
Correlation between the binding affinity and the conformational entropy of nanobody SARS-CoV-2 spike protein complexes

纳米抗体SARS-CoV-2刺突蛋白复合物的结合亲和力与构象熵的相关性

2022-07-1515
OAAI
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19
2021-09-2294
OAAI
Architecture of cell-cell junctions in situ reveals a mechanism for bacterial biofilm inhibition
2021-07-2820
OA
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2
2021-03-2944
OAAI
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 (vol 27, pg 846, 2020)
2021-02-033
OAAI
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
2021-01-22222
OAAI
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient
2020-07-31227
OAAI
Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19
2020-07-27104
OAAI